COVID-19 and its Impact on Infusion Site of Care
No Comments
COVID-19 has amplified patient expectations about the quality and safety of care, particularly for the growing number of patients with autoimmune diseases. New provider alternatives for ongoing infusion and injection therapy are reshaping how and where specialized care is delivered.